Diabetes Atlas, International Diabetes Federation: Difference between revisions
Norah.Shamin (talk | contribs) No edit summary |
Norah.Shamin (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 3: | Line 3: | ||
= Tables In IFs = | = Tables In IFs = | ||
Currently there is only new data for HealthIGTPrev% and HealthDiabetesPrev%. Check each update to see if the outdated tables have any new data. | |||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
| Line 12: | Line 13: | ||
!UsedInPreprocessorFileName | !UsedInPreprocessorFileName | ||
|- | |- | ||
|HealthDiabetesPrev% | |'''<big>HealthDiabetesPrev%</big>''' | ||
|Prevalence of diabetes | |<big>'''Prevalence of diabetes'''</big> | ||
|2003,2013-2015,2017,2019,2021,2025,2035,2040 | |<big>'''2003,2013-2015,2017,2019,2021,2025,2035,2040, 2050'''</big> | ||
| | |<big>'''2/12/2026'''</big> | ||
|1 | |<big>'''1'''</big> | ||
|HEALTH | |<big>'''HEALTH'''</big> | ||
|- | |- | ||
|HealthDiabetesPrevFemale | |'''<big>HealthIGTPrev%</big>''' | ||
|Prevalence of diabetes among females aged 20-79. | |<big>'''Prevalence of impaired glucose intolerance'''</big> | ||
|2003, 2025 | |<big>'''2003,2013-2015,2017,2019,2021,2025,2035,2040, 2050'''</big> | ||
|3/28/2009 | |<big>'''2/12/2026'''</big> | ||
|0 | |<big>'''1'''</big> | ||
|<big>'''HEALTH'''</big> | |||
|- | |||
|<small>''HealthDiabetesPrevFemale''</small> | |||
|<small>''Prevalence of diabetes among females aged 20-79.''</small> | |||
|<small>''2003, 2025''</small> | |||
|<small>''3/28/2009''</small> | |||
|<small>''0''</small> | |||
| | | | ||
|- | |- | ||
|HealthDiabetesPrevMale | |<small>''HealthDiabetesPrevMale''</small> | ||
|Prevalence of diabetes among males aged 20-79. | |<small>''Prevalence of diabetes among males aged 20-79.''</small> | ||
|2003, 2025 | |<small>''2003, 2025''</small> | ||
|3/28/2009 | |<small>''3/28/2009''</small> | ||
|0 | |<small>''0''</small> | ||
| | | | ||
|- | |- | ||
| | |<small>''HealthIGTPrevFemale''</small> | ||
|<small>''Prevalence of impaired glucose intolerance among females aged 20-79.''</small> | |||
|<small>''2003, 2025''</small> | |||
|<small>''3/28/2009''</small> | |||
|<small>''0''</small> | |||
|Prevalence of impaired glucose intolerance among females aged 20-79. | |||
|2003, 2025 | |||
|3/28/2009 | |||
|0 | |||
| | | | ||
|- | |- | ||
|HealthIGTPrevMale | |<small>''HealthIGTPrevMale''</small> | ||
|Prevalence of impaired glucose intolerence among males aged 20-79. | |<small>''Prevalence of impaired glucose intolerence among males aged 20-79.''</small> | ||
|2003, 2025 | |<small>''2003, 2025''</small> | ||
|3/28/2009 | |<small>''3/28/2009''</small> | ||
|0 | |<small>''0''</small> | ||
| | | | ||
|- | |- | ||
|HealthDiabetesPrev20-39 | |<small>''HealthDiabetesPrev20-39''</small> | ||
|Average number of people per million, between the ages 20-39, with diabetes | |<small>''Average number of people per million, between the ages 20-39, with diabetes''</small> | ||
|2003, 2025 | |<small>''2003, 2025''</small> | ||
|1/7/2009 | |<small>''1/7/2009''</small> | ||
|0 | |<small>''0''</small> | ||
| | | | ||
|- | |- | ||
|HealthDiabetesPrev40-59 | |<small>''HealthDiabetesPrev40-59''</small> | ||
|Average number of people per million, between the ages 40-59, with diabetes | |<small>''Average number of people per million, between the ages 40-59, with diabetes''</small> | ||
|2003, 2025 | |<small>''2003, 2025''</small> | ||
|1/7/2009 | |<small>''1/7/2009''</small> | ||
|0 | |<small>''0''</small> | ||
| | | | ||
|- | |- | ||
|HealthDiabetesPrev60-79 | |<small>''HealthDiabetesPrev60-79''</small> | ||
|Average number of people per million, between the ages 60-79, with diabetes | |<small>''Average number of people per million, between the ages 60-79, with diabetes''</small> | ||
|2003, 2025 | |<small>''2003, 2025''</small> | ||
|1/7/2009 | |<small>''1/7/2009''</small> | ||
|0 | |<small>''0''</small> | ||
| | | | ||
|- | |- | ||
|HealthIGTPrev20-39 | |<small>''HealthIGTPrev20-39''</small> | ||
|Average number of people per million, between the ages 20-39, with Impaired Glucose Intolerence | |<small>''Average number of people per million, between the ages 20-39, with Impaired Glucose Intolerence''</small> | ||
|2003, 2025 | |<small>''2003, 2025''</small> | ||
|1/7/2009 | |<small>''1/7/2009''</small> | ||
|0 | |<small>''0''</small> | ||
| | | | ||
|- | |- | ||
|HealthIGTPrev40-59 | |<small>''HealthIGTPrev40-59''</small> | ||
|Average number of people per million, between the ages 40-59, with Impaired Glucose Intolerence | |<small>''Average number of people per million, between the ages 40-59, with Impaired Glucose Intolerence''</small> | ||
|2003, 2025 | |<small>''2003, 2025''</small> | ||
|1/7/2009 | |<small>''1/7/2009''</small> | ||
|0 | |<small>''0''</small> | ||
| | | | ||
|- | |- | ||
|HealthIGTPrev60-79 | |<small>''HealthIGTPrev60-79''</small> | ||
|Average number of people per million. between the ages 60-79, with Impaired Glucose Intolerence | |<small>''Average number of people per million. between the ages 60-79, with Impaired Glucose Intolerence''</small> | ||
|2003, 2025 | |<small>''2003, 2025''</small> | ||
|1/7/2009 | |<small>''1/7/2009''</small> | ||
|0 | |<small>''0''</small> | ||
| | | | ||
|} | |} | ||
| Line 106: | Line 107: | ||
[[File:Image IDF 1.png|none|thumb|616x616px]] | [[File:Image IDF 1.png|none|thumb|616x616px]] | ||
Step 3: For data in the excel format navigate to: https://diabetesatlas.org/ | |||
[[File:Diabetes Altas Indicators.png|none|thumb|600x600px]] | |||
Step 4: Once you click the boxed indicators make sure you select "Age-standardised prevalence of diabetes, %" and "Age-standardised prevalence of IGT, %" respectively. | |||
Prevalence of diabetes ('''SeriesHealthDiabetesPrev%'''): 2014, 2015 and 2040 were added for prevalence of diabetes. The data for 2014 came from an atlas poster for 6th edition and all other data came from a tool on the site. | Prevalence of diabetes ('''SeriesHealthDiabetesPrev%'''): 2014, 2015 and 2040 were added for prevalence of diabetes. The data for 2014 came from an atlas poster for 6th edition and all other data came from a tool on the site. | ||
| Line 111: | Line 115: | ||
Prevalence of impaired glucose intolerance ('''SeriesHealthIGTPrev%'''): 2015 and 2040 were added for the prevalence of impaired glucose intolerance. | Prevalence of impaired glucose intolerance ('''SeriesHealthIGTPrev%'''): 2015 and 2040 were added for the prevalence of impaired glucose intolerance. | ||
These were national prevalences and not age adjusted | These were national prevalences and not age adjusted. | ||
= Data Notes = | = Data Notes = | ||
=== '''SeriesHealthDiabetesPrev%''' === | === '''SeriesHealthDiabetesPrev%''' === | ||
=== '''SeriesHealthIGTPrev%''' === | === '''SeriesHealthIGTPrev%''' === | ||
| Line 123: | Line 126: | ||
The data could be found in 6th edition. | The data could be found in 6th edition. | ||
[[File:Image idf 2.png|none|thumb|486x486px]] | [[File:Image idf 2.png|none|thumb|486x486px]] | ||
However, it was not accessible from 7th edition in pdf. No actual update. | However, it was not accessible from 7th edition in pdf. No actual update. In the next few releases this is present. | ||
=== [https://diabetesatlas.org/faqs/ What is the difference between prevalence and age-adjusted comparative prevalence in the IDF Diabetes Atlas?] === | === [https://diabetesatlas.org/faqs/ What is the difference between prevalence and age-adjusted comparative prevalence in the IDF Diabetes Atlas?] === | ||
Latest revision as of 19:24, 3 March 2026
Summary
The International Diabetes Federation (IDF) is an umbrella organization of over 230 national diabetes associations in 170 countries and territories. It represents the interests of the growing number of people with diabetes and those at risk. The Federation has been leading the global diabetes community since 1950.
Tables In IFs
Currently there is only new data for HealthIGTPrev% and HealthDiabetesPrev%. Check each update to see if the outdated tables have any new data.
| Variable | Definition | Years | Last IFs Update | UsedInPreprocessor | UsedInPreprocessorFileName |
|---|---|---|---|---|---|
| HealthDiabetesPrev% | Prevalence of diabetes | 2003,2013-2015,2017,2019,2021,2025,2035,2040, 2050 | 2/12/2026 | 1 | HEALTH |
| HealthIGTPrev% | Prevalence of impaired glucose intolerance | 2003,2013-2015,2017,2019,2021,2025,2035,2040, 2050 | 2/12/2026 | 1 | HEALTH |
| HealthDiabetesPrevFemale | Prevalence of diabetes among females aged 20-79. | 2003, 2025 | 3/28/2009 | 0 | |
| HealthDiabetesPrevMale | Prevalence of diabetes among males aged 20-79. | 2003, 2025 | 3/28/2009 | 0 | |
| HealthIGTPrevFemale | Prevalence of impaired glucose intolerance among females aged 20-79. | 2003, 2025 | 3/28/2009 | 0 | |
| HealthIGTPrevMale | Prevalence of impaired glucose intolerence among males aged 20-79. | 2003, 2025 | 3/28/2009 | 0 | |
| HealthDiabetesPrev20-39 | Average number of people per million, between the ages 20-39, with diabetes | 2003, 2025 | 1/7/2009 | 0 | |
| HealthDiabetesPrev40-59 | Average number of people per million, between the ages 40-59, with diabetes | 2003, 2025 | 1/7/2009 | 0 | |
| HealthDiabetesPrev60-79 | Average number of people per million, between the ages 60-79, with diabetes | 2003, 2025 | 1/7/2009 | 0 | |
| HealthIGTPrev20-39 | Average number of people per million, between the ages 20-39, with Impaired Glucose Intolerence | 2003, 2025 | 1/7/2009 | 0 | |
| HealthIGTPrev40-59 | Average number of people per million, between the ages 40-59, with Impaired Glucose Intolerence | 2003, 2025 | 1/7/2009 | 0 | |
| HealthIGTPrev60-79 | Average number of people per million. between the ages 60-79, with Impaired Glucose Intolerence | 2003, 2025 | 1/7/2009 | 0 |
Data Pulling Instructions
The current update came from International Diabetes Federation's Diabetes Atlas; https://diabetesatlas.org/
Step 1: access https://diabetesatlas.org/resources/
Step 2: access the various editions of the atlas and gather data from pdf files.
Step 3: For data in the excel format navigate to: https://diabetesatlas.org/
Step 4: Once you click the boxed indicators make sure you select "Age-standardised prevalence of diabetes, %" and "Age-standardised prevalence of IGT, %" respectively.
Prevalence of diabetes (SeriesHealthDiabetesPrev%): 2014, 2015 and 2040 were added for prevalence of diabetes. The data for 2014 came from an atlas poster for 6th edition and all other data came from a tool on the site.
Prevalence of impaired glucose intolerance (SeriesHealthIGTPrev%): 2015 and 2040 were added for the prevalence of impaired glucose intolerance.
These were national prevalences and not age adjusted.
Data Notes
SeriesHealthDiabetesPrev%
SeriesHealthIGTPrev%
Only find "Age-adjusted comparative prevalance" from https://diabetesatlas.org/data/en/indicators/2/.
The data could be found in 6th edition.
However, it was not accessible from 7th edition in pdf. No actual update. In the next few releases this is present.
What is the difference between prevalence and age-adjusted comparative prevalence in the IDF Diabetes Atlas?
National or regional prevalence is the actual percentage of the adult population (20-79 years) in a country or region that has diabetes. It is calculated by taking the estimated number of cases in adults and dividing by the total population in adults. The national prevalence should be used when reporting statistics for just one country or region, or when the statistics being reported are not for comparison.
Age-adjusted comparative prevalence, also referred to as comparative prevalence, is the prevalence calculated by adjusting to the age structure of a standard population. In the IDF Diabetes Atlas 10th Edition, the standard population is the UN population for 2021, 2030 or 2045. Adjusting rates is a way to make fairer comparisons between groups with different distributions. Age-adjusted rates are rates that would have existed if the population under study had the same age distribution as the “standard” population.